- Filed
- May 13, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 13, 2025 | 7.59M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $10.31M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $6.54M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $2.2M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $1.87M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $4.02M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $3.87M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $11.99M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $8.21M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $13.39M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $9.84M |
| Shares Diluted restated | Q1 2025 · Mar 31, 2024 | 357 sh |
| Capex | Q1 2025 · Mar 31, 2024 | $119K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$2.34M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $3.62M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $778K |
| Eps Diluted restated | Q1 2025 · Mar 31, 2024 | −$10.02 |
| Eps Basic restated | Q1 2025 · Mar 31, 2024 | −$10.02 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $1.93M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $669K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$3.58M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$3.51M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $470K |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $249K |
| Revenue | Q1 2025 · Mar 31, 2024 | $719K |